Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Depreciation and Depletion (2016 - 2026)

Iradimed has reported Depreciation and Depletion over the past 14 years, most recently at $291000.0 for Q1 2026.

  • Quarterly Depreciation and Depletion rose 117.16% to $291000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $952642.0 through Mar 2026, up 72.79% year-over-year, with the annual reading at $796000.0 for FY2025, 35.84% up from the prior year.
  • Depreciation and Depletion was $291000.0 for Q1 2026 at Iradimed, up from $269660.0 in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $291000.0 in Q1 2026 and troughed at $134000.0 in Q1 2025.
  • The 5-year median for Depreciation and Depletion is $149581.0 (2022), against an average of $170015.4.
  • Year-over-year, Depreciation and Depletion fell 20.55% in 2025 and then soared 117.16% in 2026.
  • A 5-year view of Depreciation and Depletion shows it stood at $149581.0 in 2022, then grew by 9.67% to $164039.0 in 2023, then decreased by 17.21% to $135806.0 in 2024, then surged by 98.56% to $269660.0 in 2025, then increased by 7.91% to $291000.0 in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Depreciation and Depletion are $291000.0 (Q1 2026), $269660.0 (Q4 2025), and $256312.0 (Q3 2025).